AstraZeneca PLC

Common Name
AstraZeneca
Country
United Kingdom
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
94,300
Ticker
AZN
Exchange
LONDON STOCK EXCHANGE
Description
AstraZeneca PLC is a multinational pharmaceutical and biopharmaceutical company known for its extensive research-driven approach to drug development. The company focuses on the discovery, development,...

Financial Statements of AstraZeneca

Below are the financial statements of AstraZeneca, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in billions of USD202420232022
Property, plant and equipment
10.25a
9.4a
8.51a
Right-of-use assets
1.4a
1.1a
0.94a
Goodwill
21.03a
20.05a
19.82a
Intangible assets
37.18a
38.09a
39.31a
Investments in associates and joint ventures
0.27a
0.15a
0.08a
Other investments
1.63a
1.53a
1.07a
Derivative financial instruments
0.18a
0.23a
0.07a
Other receivables
0.93a
0.8a
0.84a
Deferred tax assets
5.35a
4.72a
3.26a
Non-current assets
78.21a
76.07a
73.89a
Inventories
5.29a
5.42a
4.7a
Trade and other receivables
12.97a
12.13a
10.52a
Other investments
0.17a
0.12a
0.24a
Derivative financial instruments
0.05a
0.12a
0.09a
Income tax receivable
1.86a
1.43a
0.73a
Cash and cash equivalents
5.49a
5.84a
6.17a
Assets held for sale
0a
0a
0.15a
Current assets
25.83a
25.05a
22.59a
Total assets
104.04a
101.12a
96.48a
Interest-bearing loans and borrowings
-2.34a
-5.13a
-5.31a
Lease liabilities
-0.34a
-0.27a
-0.23a
Trade and other payables
-22.47a
-22.37a
-19.04a
Derivative financial instruments
-0.05a
-0.16a
-0.09a
Provisions
-1.27a
-1.03a
-0.72a
Income tax payable
-1.41a
-1.58a
-0.9a
Current liabilities
-27.87a
-30.54a
-26.29a
Interest-bearing loans and borrowings
-26.51a
-22.37a
-22.97a
Lease liabilities
-1.11a
-0.86a
-0.73a
Derivative financial instruments
-0.12a
-0.04a
-0.16a
Deferred tax liabilities
-3.31a
-2.84a
-2.94a
Retirement benefit obligations
-1.33a
-1.52a
-1.17a
Provisions
-0.92a
-1.13a
-0.9a
Income tax payable
-0.24a
0a
0a
Other payables
-1.77a
-2.66a
-4.27a
Non-current liabilities
-35.3a
-31.41a
-33.13a
Total liabilities
-63.16a
-61.95a
-59.43a
Net assets
40.87a
39.17a
37.06a
Share capital
0.39a
0.39a
0.39a
Share premium account
35.23a
35.19a
35.16a
Capital redemption reserve
0.15a
0.15a
0.15a
Merger reserve
0.45a
0.45a
0.45a
Other reserves
1.41a
1.46a
1.47a
Retained earnings
3.16a
1.5a
-0.57a
Capital and reserves attributable to equity holders of the Company
40.79a
39.14a
37.04a
Non-controlling interests
0.09a
0.02a
0.02a
Total equity
40.87a
39.17a
37.06a

Verified Sources Behind AstraZeneca’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore AstraZeneca’s data sources below and access millions more through our Disclosure Search.

a. AstraZeneca's Annual Report 2024
Trace every data point back to AstraZeneca’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?